Crossmark

Development of patient reported outcome measures assessing tumor pain intensity and tumor pain interference for individuals with neurofibromatosis type 1 and plexiform neurofibromas: qualitative findings

Crossref DOI link: https://doi.org/10.1186/s41687-025-00877-2

Published Online: 2025-04-30

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Al Ghriwati, Nour

Struemph, Kari

Martin, Staci

Little, Paige

Baker, Melissa

Levine, Jason

MacKenzie, Cynthia

Tonsgard, James

Schorry, Elizabeth K.

Walsh, Karin S.

Wolters, Pamela L. https://orcid.org/0000-0001-9319-6281
Funding

Funding for this research was provided by:

National Cancer Institute
License Information

Text and Data Mining valid from 2025-04-30

Version of Record valid from 2025-04-30
More Information

Article History

Received: 27 June 2024

Accepted: 28 March 2025

First Online: 30 April 2025

Declarations

:

: This research study was approved by the Institutional Review Board of the National Cancer Institute and performed in accordance with the Declaration of Helsinki.

: Not applicable.

: The authors declare that they have no competing interests.

Document is current

Any future updates will be listed below